AG 701
Latest Information Update: 27 Nov 2001
At a glance
- Originator Antigenics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 27 Nov 2001 Discontinued-Preclinical for Herpes simplex virus infections in USA (Unknown route)
- 18 Apr 2001 New profile
- 18 Apr 2001 Preclinical development for Herpes simplex virus infections in USA (Unknown route)